BioNTech

BioNTech

BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Our diversified oncology portfolio of product candidates includes individualized and off-the-shelf mRNA cancer vaccines, targeted therapies comprising chimeric antigen receptor T cells and antibody-drug conjugates, and novel immunomodulators.

Breast Cancer, Gastrointestinal (Colorectal) Cancer, Lung Cancer, Antibodies, Biotechnology, Immunotherapy, Personalized Medicine

Yes

Yes